| Literature DB >> 36258720 |
Dalia Sherief1, Asmaa Hassan1, Eman Habeeb1, Nahla Nosair1, Maaly Mabrouk2, Sarah Shoeib2, Heba Reyad3, Tamer Haydra4, Mona Watany2.
Abstract
The present study aimed to detect the prevalence of NOTCH1 c.7541-7542delCT mutation in Egyptian CLL patients using HRM assay and to assess its relation to patients' survival. The study included 50 newly diagnosed treatment-naïve CLL patients and 50 age and sex matched healthy controls. NOTCH1 c.7541-7542delCT mutation was detected using High-resolution melting (HRM) assay and direct Sanger sequencing. Outcome parameters included progression free survival (PFS) and overall survival (OS). NOTCH1 c.7541-7542delCT mutation was detected in 5 (10.0%) of CLL patients. No controls had NOTCH1 c.7541-7542delCT mutation. Similar results were obtained by direct Sanger sequencing yielding a sensitivity and specificity of 100.0% for HRM in detection of NOTCH1 c.7541-7542delCT mutation in the studied patients. In univariate analysis, predictors of OS included Trisomy 12, high LDH, presence of NOTCH1 c.7541-7542delCT mutation and lack of CR. In multivariate analysis, only lack of CR was found as a significant predictor of OS. HRM analysis is a sensitive method for detection of NOTCH1 c.7541-7542delCT mutation in CLL patients. This mutation may be linked to poor disease prognosis.Entities:
Keywords: Chronic lymphocytic leukemia; DNA sequencing; High-resolution melting analysis; NOTCH1 mutations; Prognosis
Year: 2022 PMID: 36258720 PMCID: PMC9569265 DOI: 10.1007/s12288-022-01535-z
Source DB: PubMed Journal: Indian J Hematol Blood Transfus ISSN: 0971-4502 Impact factor: 0.915